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doi:10.1016/j.pedneo.2011.06.002Background: Pleural effusion is rare and includes several disease entities in the neonatal
period. The aim of this study was to investigate the etiology, management, and outcome of
neonatal pleural effusions.
Methods: We retrospectively collected all neonates who were admitted to the neonatal inten-
sive care unit of Chung Shan Medical University Hospital, Taichung, Taiwan, with discharge
diagnosis of pleural effusion, chylothorax, hydrothorax, hemothorax, and empyema, from
January 1999 to December 2009. The characteristics, etiology, management, and outcome
were analyzed.
Results: There were 21 patients identified, 16 males (76%) and 5 females (24%). Eight patients
(38%) had primary and 13 patients (62%) had secondary etiologies. The etiologies included four
parapneumonic effusions or empyema (19%); nine chylothorax (42.8%) with four congenital and
five iatrogenic after thoracic surgery; three percutaneously inserted central venous catheter
extravasation (14%); one umbilical venous catheter extravasation (4.7%); three hydrops fetalis
(14%); and one congestive heart failure (4.7%). Fifteen patients (71%) needed chest tube place-
ment. Conservative management with complete cessation of enteral feedings and use of total
parenteral nutrition followed with infant formula containing medium-chain triglyceride was
successful in six of the patients (67%) with chylothorax. There were two patients (22%) with
chylothorax who received somatostatin administration; one was successful and the other
one failed. Thoracic duct ligation was performed uneventfully in two patients with acquired
chylothorax. There were three mortalities (14.3%) in this study, which were related to causes
other than pleural effusion.t of Pediatrics, Chung Shan Medical University Hospital, No. 110, Chien-Ku North Road, Section 1,
tw (J.-Y. Chen).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
252 Y.-T. Shih et alConclusions: Pleural effusions in the neonatal stage may result from chylothorax, hydrops
fetalis, extravasation of percutaneously inserted central venous catheter, parapneumonic
effusion, congestive heart failure, or other less frequently occurring conditions. Diagnostic
chest tap is required for subsequent management. Good outcome is the rule except in hydrops
fetalis, which carries high mortality rate.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Pleural effusion is defined as fluid accumulation in the
pleural space, which exists between the parietal pleura of
the chest wall and the visceral pleura of the lung. Both
layers filter into the space fluid that has been reabsorbed
from the lymphatics. Any change of the pulmonary venous
hydrostatic pressure, lymphatic pressure, blood oncotic
pressure, and local tissue trauma or inflammation will lead
to pleural effusion.1 It is not surprising that so many
disorders account for the formation of neonatal pleural
effusion. In the literature, causes, such as parapneumonic
effusion, empyema, chylothorax, hydrothorax, hemo-
thorax, leakage of central-line fluid, or parenteral nutri-
tion, have been reported.2 The incidence is rare, ranging
from 5.5 per 10,000 to 2.2%.2,3 Pleural effusion may occur
at any time during the neonatal period, at birth, or ante-
natally, diagnosed by ultrasound. It may be asymptomatic
or result in respiratory distress. Chest radiography and
ultrasound are helpful in pleural fluid recognition. Precise
diagnosis of the etiology is important for subsequent
management. Therefore, thoracentesis or thoracostomy for
pleural fluid analysis is mandatory. The aim of this study
was to investigate the etiology, management, and outcome
of neonatal pleural effusions in one tertiary neonatal care
center.
2. Methods
We retrospectively searched from the hospital computer
database for discharge diagnosis of pleural effusion, chy-
lothorax, hydrothorax, hydrops fetalis, hemothorax, and
empyema from January 1, 1999, to December 31, 2009. All
neonates who were admitted to the neonatal intensive care
unit (NICU) of Chung Shan Medical University Hospital,
Taichung, Taiwan, and had the above diagnosis, were
included. All patients with pleural effusion were diagnosed
by chest radiography. Chest echography was performed for
most patients to calculate the volume and for subsequent
follow-up. Thoracentesis was performed for pleural fluid
analysis. Chest tube was inserted if there was persistent
respiratory distress after thoracentesis. The volume of
drained fluid was recorded by total volume per kilogram in
the first day of drainage. The diagnostic criteria for chylo-
thorax in our NICU were according to the proposal of
Bϋttiker et al4: total white cell count 1000/mL, with
a lymphocyte fraction> 80% and triglyceride lev-
els> 110 mg/dL. Hydrops fetalis was defined as excess fluid
accumulation in the fetus and had characteristic findings,
such as skin edema, pleural effusion, pericardial effusion,
ascites, and polyhydramnios. Hemothorax meant thepresence of blood in the pleural space. Empyema was
defined as positive pleural effusion culture or purulent
pleural effusion with elevated white blood cell count and
a higher percentage of polymorphonuclear cells (PMNs).
The presence of high level of glucose and triglyceride
content with low cell count in the pleural effusion sug-
gested the extravasation of parenteral nutrition from
central venous catheter.
Clinical information of sex, gestational age, birth
weight, age, delivery method, unilateral or bilateral,
prenatal diagnosis, clinical presentation, laboratory data of
pleural effusion, duration and volume of pleural effusion,
associated diseases, diagnosis, management, length of
each therapeutic modality, morbidity, and mortality were
obtained from the charts. Pleural effusion data include the
appearance, pH, density, red blood cell count, white blood
cell count with differential count, percentage of lympho-
cytes, percentage of PMNs, protein, glucose, lactate
dehydrogenase, cholesterol, and triglyceride. Data were
expressed as median (range) and number (percentage).
Descriptive analysis with SPSS version 16.0 software
package was carried out.
3. Results
There were 21 patients identified, 16 males (76%) and 5
females (24%). The median gestational age was 32 weeks
(range, 25e39 weeks). There were 7 full-term babies and
14 premature babies. The birth weight ranged from 780 g to
3110 g. There were 3 twins and 18 singletons. Cesarean
delivery was the mode of delivery performed in 16 patients
and vaginal delivery in 5. The site of occurrence was
unilateral in 14 patients (6 in the right and 8 in the left) and
bilateral in 6 patients. The site of occurrence was not
recorded in one patient with acquired chylothorax after
thoracic surgery. Prenatal diagnosis was made in two
patients; one had hydrops fetalis and the other had
congenital chylothorax.
3.1. Etiologies and initial clinical presentation
The etiologies of our neonates with pleural effusion and the
percentage of each category are listed in Table 1. Eight
patients (38%) were primary and 13 patients (62%) were
secondary. Secondary etiologies were more frequent than
primary etiologies. Chylothorax was the most common
etiology with nine patients (42.8%), and acquired chylo-
thorax was slightly predominant. The initial clinical presen-
tations were acute onset of dyspnea and hypoxia. All five
cases with iatrogenic chylothorax occurred after thoracic
surgery; their clinical information is summarized in Table 2.
Table 1 Etiologies of neonates with pleural effusion.
Diagnosis No. of patients
(nZ 21)
Percentage
Primary 8 38
Congenital chylothorax 4 19
Hydrops fetalis 3 14
Congestive heart failure 1 4.8
Secondary 13 62
Parapneumonic
effusion/empyema
4 19
Acquired chylothorax 5 23.8
PICC extravasation 3 14
UVC extravasation 1 4.8
PICCZ percutaneously inserted central venous catheter;
UVCZ umbilical venous catheter.
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management, and outcome
Laboratory data, duration, volume, management, and
mortality of pleural effusions are summarized in Table 3.
One patient who suffered from acquired chylothorax after
Blalock-Taussig shunt for tetralogy of Fallot had effusion
duration of 34 days. She did not respond to medium-chain
triglyceride formula and somatostatin administration;
hence, thoracic duct ligation was performed. Fifteen
patients (71%) needed chest tube placement. One patient
with congenital chylothorax had a resolution of pleural
effusion after complete cessation of enteral feedings and
institution of total parenteral nutrition (TPN) followed by
medium-chain triglyceride formula without chest tube
placement. Another one with congenital chylothorax did
not respond to complete cessation of enteral feedings but
was successfully treated by octreotide.
One patient with hydrops fetalis, congenital anomaly,
and congenital heart disease, who received aggressive
resuscitation immediately after delivery but died 6 hours
later, did not have chest tube insertion, either. The pleural
effusion of the other two patients with hydrops fetalis
resolved after thoracostomy. The drained volume was
greatest in the hydrops fetalis group at 225.6 mL/kg/d. AllTable 2 Clinical summary of acquired chylothorax after thorac
Case Cardiac diagnosis Surgery
1 CoA, single ventricle, DORV, PDA, L-TGA CoA repair, P
2 TOF, PA, DAA BT shunt
3 VSD, IAA Type B, PDA, situs solitus Aortoplasty,
4 Situs solitus, single ventricle, PS, PDA Rashkind bal
5 VSD, PDA VSD patch re
BT shuntZ Blalock-Taussig shunt; CoAZ coarctation of the aorta; D
IAAZ interrupted aortic arch; L-TGAZ L-transposition of the grea
atresia; PDAZ patent ductus arteriosus; PSZ pulmonary stenosis; TOfour patients with parapneumonic effusion or empyema
were treated conservatively and successfully with paren-
teral antibiotics. Urokinase or video-assisted thoracoscopy
was not used.
Even with the same etiologies and management
protocol, the duration of effusion was variable. In the
central venous extravasation group, central lines were
removed after diagnosis, and the median duration of effu-
sions was 2.5 days (range, 2e4 days). The patients in this
group had the fastest resolution of pleural effusion. One
patient had a second episode of pleural effusion with
cardiac tamponade, which resolved after pericardiocent-
esis. She was subsequently diagnosed with a double supe-
rior vena cava associated with venous thrombosis in the left
brachiocephalic vein and left superior vena cava. Another
patient had fungemia. Candida parapsilosis was found in
the cultures taken from the blood, urine, pleural effusion,
and the percutaneously inserted central venous catheter
(PICC) tip of this patient.
Two patients with congenital chylothorax had special
associated diseases. One patient who had floppy baby
syndrome was presented immediately after delivery. The
muscle biopsy revealed myotubular myopathy. Another
patient had carotid venous malformation and received
a prolonged course of treatment. The causes for the three
cases of hydrops fetalis were idiopathic in one and
congenital heart disease in the other two.
There were three mortalities (14.3%) in this series. Two
patients with hydrops fetalis and congenital heart anomaly
died because of cardiopulmonary failure. One in the
extravasation of TPN group died because of perforated
necrotizing enterocolitis. There was no mortality directly
related to pleural effusion.
4. Discussion
In the retrospective study by Rocha et al,2 62 neonates
were identified over an 8-year period in the NICU of six
medical centers in the north of Portugal. Pleural effusions
were congenital in 32% and acquired in 68%. The disease
category distribution was similar to that in our study. Less
frequently occurring conditions included twin-to-twin
transfusion, Escherichia coli infection, meconium perito-
nitis with hypoproteinemia, superior vena cava syndrome,
hypoproteinemia, and nephrotic syndrome with renalic surgery.
Treatment Duration of
effusion (d)
A banding Thoracic duct ligation 2
MCT diet, somatostadin,
thoracic duct ligation
34
VSD patch repair Chest tube, MCT diet 6
loon, septostomy Chest tube, MCT diet 5
pair, PDA ligation Chest tube 5
AAZ double aortic arch; DORVZ double-outlet right ventricle;
t arteries; MCTZmedium-chain triglyceride; PAZ pulmonary
FZ tetralogy of Fallot; VSDZ ventricular septal defect.
Table 3 Characteristics, management, and outcome of neonates with pleural effusion.
Characteristics Chylothorax
(nZ 9)
Hydrops fetalis
(nZ 3)
CHF
(nZ 1)
Parapneumonic
effusion/empyema
(nZ 4)
Venous catheter
extravasation
(nZ 4)
Gestational age (wk) 35 (26e38) 33 (32e33) 30 31 (25e36) 29 (26e30)
Birth weight (g) 2185 (1026e2636) 2216 (2050e2400) 1998 1610 (840e1916) 1108 (780e1578)
Age of occurrence (d) 9 (5e46) 1 (1e10) 8 13.5 (6e38) 11 (7e23)
pH 7 (6.5e8) 7.5 (7.5e7.5) 7 7 (7e8) 6.5 (6.5e7)
Density 1.02 (1.013e1.024) 7.5 (7.5e7.5) d 1.005 (1e1.01) 1.02 (1.012e1.025)
Red blood cell
count (cells/mL)
5300 (250e23,000) 7400 (4250e143,750) 13,250 350 (198e16,000) 530 (100e4540)
White blood cell count
(cells/mL)
3275 (150e7250) 835 (550e1120) 9200 2736 (1900e99,200) 1340 (350e4280)
Percentage of lymphocytes 88.5 (66e96) 63 (27e99) 99 0 (0e2) 6 (0.5e7)
Percentage of
polymorphonuclear cells
1.5 (1e34) 25.5 (1e50) 0.5 85 (83e95) 81 (8e83)
Protein (g/dL) 2.6 (0.47e2.8) d 3 1.5 (1e3) 1.4 (0.5e1.8)
Glucose (mg/dL) 109.5 (76e290) d 108 121 (63e467) 236 (201e574)
Lactate dehydrogenase (U/L) 180.5 (146e526) d 1217 424 (190e1589) 220 (119e606)
Cholesterol (mg/dL) 29 (28e30) d d 60.5 (26e95) 57.5 (20e95)
Triglyceride (mg/dL) 256.5 (64e594) d d 46 495 (352e638)
Nil per os duration (d) 13 (3e60) 6 (1e10) 0 0 0
Received TPN 4 2 1 0 0
Chest tube placement 3 (75) 2 (67) 1 (100) 2 (50) 2 (50)
Drained volume (mL/kg/d) 34.5 (15.6e109) 126 (27.1e225.6) 12.5 17.5 (16.2e22.7) 12.5 (11.5e23.4)
Duration of effusions (d) 6 (3e60) 4 (1e13) 12 4.5 (3e25) 2.5 (2e4)
Received octreotide 2 (22) 0 0 0 0
Received thoracic
duct ligation
2 (22) 0 0 0 0
Mortality 0 2 (67) 0 0 1 (25)
Values are expressed as median (range) or n (%).
CHFZ congestive heart failure; TPN Z total parenteral nutrition.
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pulmonary hypoplasia.2
Chylothorax was the most common cause of neonatal
pleural effusion (9 of 21, 43%) in our study. Congenital
chylothorax accounted for 44% and postoperative chylo-
thorax for 56% of cases. The range of age of occurrence of
nonacquired chylothorax was 5e46 days and was 2e44 days
for postoperative chylothorax. In Rocha et al’s2 report,
congenital chylothorax was associated with hydrops fetalis
in one-third of the cases and had mainly bilateral involve-
ment. There was no such association found in our study.
Bϋttiker et al4 established the criteria for chylothorax:
total white cell count 1000 cells/mL with a lymphocyte
fraction> 80% and triglycerides> 110 mg/dL. One of our
patients with gestational age of 26 weeks and diagnosed
with chylothorax at 46 days of age had lymphocyte fraction
of 66% with 34% PMNs. There may have been concomitant
infection or possible irritation of the pleura that resulted in
higher PMN counts.
The disease associations of congenital chylothorax found in
our study were myotubular myopathy (nZ 1) and carotid
arteriovenous malformation (nZ 1). Myotubular myopathy
association was also reported by Smets.5 He reported
a newborn baby with X-linked myotubular myopathy who
developed a clinically relevant chylothorax in his secondweek
of life,which requireddrainageand treatmentwithoctreotideacetate.Other associationswith chromosomeanomalies, such
as Turner syndrome, Noonan syndrome, and Down syndrome
with generalized lymphangiomatosis, were also reported.
Complete cessation of enteral feedings and use of TPN
or formula that contains medium-chain triglyceride reduce
the chyle flow and can lead to closure of the thoracic duct
spontaneously. This treatment was successful in six of nine
(67%) of our patients. However, the loss of protein,
lymphocyte, and humoral antibodies leads to an immuno-
compromised state, which may precipitate to infection
throughout the course.
The successful use of continuous administration of
octreotide (a long-acting somatostatin analog) has been
reported in several small series. The dosage of octreotide
used varied between 0.3 mg/kg/h and 40 mg/kg/h. The
chyle that drained was reduced within 1e2 days. The chest
tube can often be removed within 1 week, but some would
be delayed up to 2 weeks.6 We only had experience with
two patients, both of whom showed slow improvement
after octreotide administration without any side effect.
The reasons for the slow improvement could be high central
venous pressure or severe thoracic duct injury after
thoracic surgery. Somatostatin and octreotide are generally
safe. Adverse reactions include cramp, nausea, diarrhea,
fatty stool, flatulence, liver dysfunction, hyperglycemia,
hypothyroidism, and necrotizing enterocolitis.6
Neonatal pleural effusions 255Surgical intervention for pleural effusion, such as
thoracic duct ligation, pleuroperitoneal shunts, or pleu-
rodesis, is recommended after medical therapy fails.7 Two
of our patients in the postoperative chylothorax group had
uneventful thoracic duct ligations.
PICC is widely used in NICU worldwide for administering
TPN to premature babies. Several complications have been
reported, including pericardial effusion with or without
cardiac tamponade, pleural effusion, ascites, venous
thrombosis, catheter removal difficulties, phlebitis, and
infection.8,9,10 The prevalence of parenteral fluid extrava-
sation from central venous catheter was 0.05e1.1%.11 The
reported mechanisms include (1) vessel perforation during
catheterization; (2) retrograde passage of a central venous
catheter into the lymphatic duct; (3) erosion of the vein;
and (4) hyperosmotic endothelial damage leading to
increased vascular permeability.12,13 In our series, all of the
tip positions of PICC and umbilical venous catheter were
well located in the superior and inferior vena cava. There
was no evidence of vessel perforation. The PICC used in our
NICU was Bard Per-Q-Cath (Salt lake city, UT, USA), made of
silicone-rubber material, and the overall risk of effusion
appeared to be small. The presence of high level of glucose
and triglyceride content with low cell counts in the drained
fluid suggested the extravasation of parenteral nutrition.14
Hydrops fetalis is a conditionofexcessfluidaccumulation in
the fetus. It has several characteristic antenatal ultrasono-
graphic findings, such as skin edema, pleural effusion, peri-
cardial effusion, ascites, and polyhydramnios. Abrams et al15
reviewed retrospectively a total of 253,651 discharges from
162 NICUs, and hydrops fetalis was found in 598 patients.
Congenital heart problems were the most common diagnosis
(13.7%). Other causes included abnormalities in heart rate
(10.4%), twin-to-twin transfusion (9%), congenital anomalies
(8.7%), chromosomal abnormalities (7.5%), congenital viral
infections (6.7%), congenital anemia (5%), and congenital
chylothorax (3.2%).The survival rateof hydrops fetaliswas less
than 50%.16 The causes of hydrops fetalis can be determined
antenatally in 50e85% of the cases.17 Aggressive prenatal
intervention improves the survival rate of hydrops fetalis.
Parapneumonic effusions or empyema occur as a compli-
cation of bacterial pneumonia. Pathogens reported in the
literature include Staphylococcus aureus, group A Strepto-
coccus, Bacteroides fragilis, E coli, Klebsiella, Pseudomonas
aeruginosa, and Acinetobacter caloacesticus.18,19 However,
no pathogen was identified in the pleural fluid or blood from
our four patients. This may be the result of the concurrent
antibiotics usage. Empyema is defined as pus noted in the
pleural fluid, positive culture, or positive Gram’s stain. It can
be divided into three stages: (1) exudative stage, (2) fibri-
nopurulent stage, and (3) organizational stage. Chest ultra-
sound is helpful in the diagnosis of pleural effusion and for
monitoring theprogressionof parapneumoniceffusion.Chest
drain placement is indicated in cases of enlarging effusion or
respiratory compromise. If there is fibrin deposition and peel
formation, fibrinolysis with urokinase can shorten the
hospital stay. Surgical interventionwith thracotomyor video-
assisted thoracoscopy is advised if treatment with chest
drainage with or without fibrinolysis has failed.20
Congestive heart failure results in bilateral pleural
effusion. Diagnostic thoracentesis is indicated if the effu-
sion is not bilateral or the patient is febrile.In conclusion, pleural effusion in the neonatal stage may
result from chylothorax, hydrops fetalis, extravasation of
PICC or umbilical venous catheter, parapneumonic effusion,
congestive heart failure, or other less common conditions.
Diagnostic chest tap for pleural fluid analysis is essential for
subsequent management. Good outcome is the rule except
in hydrops fetalis, which carries a high mortality rate.References
1. Rocha G. Pleural effusions in the neonate. Curr Opin Pulm Med
2007;13:305e11.
2. Rocha G, Fernandes P, Rocha P. Pleural effusions in the
neonate. Acta Paediatr 2006;95:791e8.
3. Long WA, Lawson EE, Harned JRHS, Kraybill EN. Pleural effu-
sions in the first days of life: a prospective study. Am J Peri-
natol 1984;1:190e4.
4. Bϋttiker V, Fanconi S, Burger R. Chylothorax in children. Guide-
lines for diagnosis and management. Chest 1999;116:682e7.
5. Smets K. X-linked myotubular myopathy and chylothorax.
Neuromuscul Disord 2008;18:183e4.
6. Kalomenidis I. Octreotide and chylothorax. Curr Opin Pulm
Med 2006;12:264e7.
7. Begbetti M, Scala GL, Belli D, Bugmann P, Kalangos A,
Coultre CL. Etiology and management of pediatric chylothorax.
J Pediatr 2000;136:653e8.
8. Pabalan MJU, Wynn RJ, Reynolds AM, et al. Pleural effusion
with parenteral nutrition solution: an unusual complication of
an “appropriately” placed umbilical venous catheter. Am
J Perinatol 2007;24:581e6.
9. Rejjal AR, Galal MO, Nazer HM, Karim AA, Osba YA. Compli-
cations of parenteral nutrition via an umbilical vein catheter.
Eur J Pediatr 1993;152:624.
10. Ohki Y, Yoshizawa Y, Watanabe M, Kuwashima M, Morikawa A.
Complications of percutaneously inserted central venous
catheters in Japanese neonates. Pediatr Int 2008;50:636e9.
11. Been JV, Degraeuwe PLJ. Pleural effusion due to intra-
abdominal extravasation of parenteral nutrition. Pediatr Pul-
monol 2008;43:1033e5.
12. Keeney SE, Richardson CJ. Extravascular extravasation of fluid
as a complication of central venous lines in the neonate.
J Perinatol 1995;15:284e8.
13. Madhavi P, Jameson R, Robinson MJ. Unilateral pleural effusion
complicating central venous catheterisation. Arch Dis Child
Fetal Neonatal Ed 2000;82:F248e9.
14. Wolthuis A, Landewe´ RB, Theunissen PH, Westerhuis LW. Chy-
lothorax or leakage of total parenteral nutrition? Eur Respir J
1998;12:1233e5.
15. Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis:
a retrospective review of cases reported to a large national
database and identification of risk factors associated with
death. Pediatrics 2007;120:84e9.
16. Yang YH, Teng RJ, Tang JR, Yau KI, Huang LH, Hsieh FJ.
Etiology and outcome of hydrops fetalis. J Formos Med Assoc
1998;97:16e20.
17. Sohan K, Carroll SG, Fuente SDL, Soothill P, Kyle P. Analysis of
outcome in hydrops fetalis in relation to gestational age at
diagnosis, cause and treatment. Acta Obstet Gynecol Scand
2001;80:726e30.
18. Thaarup J, Ellermann-Eriksen S, Stjernholm J. Neonatal pleural
empyema with group A streptococcus. Acta Paediatr 1997;86:
769e71.
19. Gupta R, Faridi MM, Gupta P. Neonatal empyema thoracis.
Indian J Pediatr 1996;63:704e6.
20. Proesmans M, Boeck KD. Clinical practice: treatment of
childhood empyema. Eur J Pediatr 2009;168:639e45.
